Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.

No abstract is available for this paper.

• Publication year

  1977

• Venue

  Transactions of the Association of American Physicians

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• The role of the complement system in hereditary angioedema.

  2017cites this paper
• Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade.

  2017cites this paper
• Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.

  2014cites this paper
• Cooperation between Complement and Kinin Systems in Angioedema Episodes

  2014cites this paper
• Bradykinin-mediated diseases.

  2014cites this paper
• A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.

  2013cites this paper
• Role of the B1 bradykinin receptor and gC1qR/p33 in angioedema.

  2013cites this paper
• Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy.

  2010cites this paper
• The bradykinin-forming cascade and its role in hereditary angioedema.

  2010cites this paper
• C1 inhibitor, a multi-functional serine protease inhibitor

  2010cites this paper
• Hereditary angioedema: a current state-of-the-art review, III: mechanisms of hereditary angioedema.

  2008cites this paper
• Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma.

  2008cites this paper
• Endothelial cells are a target of both complement and kinin system.

  2008cites this paper
• The deficiency of C1 inhibitor and its treatment.

  2007cites this paper
• Mechanism of angioedema in first complement component inhibitor deficiency.

  2006cites this paper
• Novel therapies for hereditary angioedema.

  2006cites this paper
• Hereditary angioedema: the clinical syndrome and its management in the United States.

  2006cites this paper
• Formation of bradykinin: a major contributor to the innate inflammatory response.

  2005cites this paper
• Complement and Its Receptors in Infection

  2004cites this paper
• The first component of human complement (C1): Activation and control

  2004cites this paper
• Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

  2004cites this paper
• Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor.

  2002influential citation
• C1-inhibitor deficiency and angioedema.

  2001cites this paper
• Hereditary Angioneurotic Edema: Review of the Literature

  2000cites this paper
• Brief communications Local bradykinin generation in hereditary angioedema

  1999cites this paper
• Idiopathic nonhistaminergic angioedema.

  1999cites this paper
• Local bradykinin generation in hereditary angioedema.

  1999cites this paper
• Plasma bradykinin in angio-oedema.

  1998cites this paper
• Activation of the coagulation cascade in C1-inhibitor deficiencies.

  1997cites this paper
• The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation.

  1997cites this paper
• Bradykinin Formation in Allergic Diseases and Hereditary Angioedema

  1997cites this paper
• Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability‐enhancing activities

  1994cites this paper
• Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid.

  1994cites this paper
• Autoantibodies against complement components and their effects on complement activity

  1993cites this paper
• Solid and fluid phase assays for bacterial plasminogen activators

  1993cites this paper
• C1-inhibitor and its genetic alterations in hereditary angioneurotic edema.

  1993cites this paper
• Urticaria and angioedema.

  1992cites this paper
• The kallikrein-kinin system in inflammation.

  1989cites this paper
• Urine-histamine levels in patients with hereditary angioedema (HAE).

  1988cites this paper
• Complement and Complement Deficiencies

  1987cites this paper
• The hereditary and acquired deficiencies of complement.

  1985cites this paper
• Genetic Deficiencies of the Complement System

  1985cites this paper
• Urticaria and angioedema.

  1983cites this paper
• 4 Hormonal Treatment of Hereditary Angioneurotic Oedema: an Important use of Anabolic Steroids

  1983cites this paper
• The active site of human C4a anaphylatoxin.

  1983cites this paper
• Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin.

  1983cites this paper
• Hereditary Angioedema: An Appraisal of 104 Cases

  1982cites this paper
• The C1 esterase inhibitor and hereditary angioedema

  1982cites this paper
• HORMONE BINDING GLOBULIN LEVELS IN PATIENTS WITH HEREDITARY ANGIOOEDEMA DURING TREATMENT WITH DANAZOL *

  1981cites this paper
• The Complement System

  1981cites this paper
• Molecular aspects of complement activation

  1981cites this paper
• Allergy and the Skin

  1981cites this paper
• Management of urticaria and angioedema.

  1980cites this paper
• Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

  1980cites this paper
• Clinical and biochemical effects of impeded androgen (oxymetholone) therapy of hereditary angioedema.

  1979cites this paper
• Danazoltherapie des hereditären Angioödems*

  1979cites this paper
• Hereditary angioneurotic edema.

  1979cites this paper
• The "cure" of an inherited disease.

  1978cites this paper